1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts

MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts

Summary

Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. Since their introduction in patients in 1991, aortic stent graft devices have gained wide acceptance and availability, with their adoption fueled in great part by advances in stent-graft design and by a variety of devices for various anatomic features. Over time, these devices have gained traction for use in patients with ruptured aneurysms because they are minimally invasive and have shorter recovery times.

Brazil accounts for about 5% of the aortic stent grafts market, which is a substantial part of the world market. Moreover, Brazil is extremely dependent on imported products. Finally, the South American market is similar to that of China in that it also has a local marketplace of players that capitalize on the public sector by offering cheaper prices on products. As multinationals offer new products in these markets, the firms that will have an added edge will be the firms with local sales offices since within a year of a product launch, local manufacturing tends to replicate and sell the devices to the public healthcare organizations.

Scope

- An overview of Aortic Stent Grafts, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized South America Aortic Stent Grafts market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Aortic Stent Grafts.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Aortic Stent Grafts sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

- Understand the trends shaping and driving the South America Aortic Stent Grafts market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in South America Aortic Stent Grafts market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in South America Aortic Stent Grafts market landscape? Identify, understand and capitalize.

Table Of Contents

MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts
1 Table of Contents

2 Introduction 19
2.1 Catalyst 20
2.2 Related Reports 21
2.3 Upcoming Related Reports 21
3 Industry Overview 22
3.1 Overview 22
3.2 Indications 23
3.2.1 Aortic Abdominal Aneurysm 23
3.2.2 Thoracic Aortic Aneurysm 24
3.2.3 Aortic Dissection 25
3.3 Clinical Outcomes 26
3.3.1 Lifestyle Changes 27
3.3.2 Medication 28
3.3.3 Open Surgery 28
3.3.4 Endovascular Repair 29
3.4 Procedure Trends 31
3.4.1 South America 31
3.5 Market Access 32
3.5.1 Adoption 33
3.5.2 Regulation 37
3.5.3 Reimbursement 38
3.6 Regulatory Issues/Recalls 39
3.6.1 Anaconda Back on the Market in March 2014 after a Voluntary Recall of Anaconda by Vascutek 39
3.6.2 Terminated FDA's Class II Recall of TriVascular's Ovation Prime in April 2014 40
3.7 Mergers, Deals, and Acquisitions 40
3.7.1 Medtronic Acquires Covidien 40
3.7.2 TriVascular Launches $100m Initial Public Offering 40
3.7.3 Lombard Medical Pursues US Initial Public Offering 40
3.7.4 TriVascular Raises $40m in Series E Financing 41
3.7.5 LifeTech Scientific Creates Partnership with Medtronic 41
3.7.6 LeMaitre Vascular Terminates Distribution Agreement with Endologix 41
3.7.7 Jotec Enters Licensing Agreement with Hydromer 41
3.7.8 Endologix Public Offering of Notes 41
3.7.9 Aptus Endosystems Secures Financing 42
3.7.10 Altura Medical Secures Financing 42
3.7.11 Endologix Acquires Nellix Endovascular 42
3.8 Economic Impact 42
3.8.1 Economic Impact of Aneurysms 43
3.8.2 Treatment Costs of Aortic Aneurysms 44
4 Unmet Needs 46
4.1 Addressing the Complications 46
4.1.1 Endoleaks 46
4.1.2 Ischemic Complications 47
4.1.3 Limb Thrombosis 47
4.1.4 Infection 48
4.1.5 Paraplegia in Thoracic Aortic Aneurysm 48
4.2 The Seal and Landing Zone 49
4.3 Short Neck 50
4.4 Cost Containment 51
4.5 More Low Profile Systems 51
4.6 Customized Fenestrated Stent Grafts 52
4.7 Multi-Branch Stent Grafts 53
4.8 Thoracic Endovascular Aneurysm Repair Unmet Needs 54
4.9 Long-Term Clinical Data 54
5 Market Opportunity Analysis 56
5.1 Emerging Markets 56
5.2 Thoracic Aortic Disease Market 57
5.3 Addition of Physician Training Programs 57
5.4 Disruptive Technologies 58
5.5 Minimally Invasive Trend 59
6 Market Drivers, Barriers, and Substitutes 60
6.1 Driver: Rising Disease Prevalence 60
6.1.1 Diabetes Mellitus 60
6.1.2 Hypertension 60
6.1.3 Obesity 60
6.1.4 Tobacco Use 61
6.2 Driver: Aging 61
6.3 Driver: Imaging 62
6.4 Driver: Improved Clinical Outcomes with Endovascular Therapy 63
6.5 Driver: Time Savings 64
6.6 Driver: Patient Demand and Awareness 64
6.7 Driver: Technological Developments 65
6.7.1 Custom Branched and Fenestrated Stent Grafts 65
6.7.2 Low Profile Delivery Systems 65
6.8 Driver: Rising Competition and Innovation 67
6.9 Barrier: Availability of Venture Capital 67
6.10 Barrier: Burden of Rising Regulation 68
6.11 Barrier: High Treatment Cost 69
6.12 Barrier: Proving Long-Term Efficacy 70
6.13 Barrier: High Radiation Dosages with Excessive Imaging 70
6.14 Surgical Limitations 71
6.15 Barrier: Medical Device Excise Tax 71
6.16 Substitute: Open Surgery 72
6.17 Substitute: Chimney Technique versus Fenestrated Grafts 73
7 Competitive Assessment 75
7.1 Overview 75
7.2 Key Marketed Products 75
7.2.1 Endovascular Aneurysm Repair and Thoracic Endovascular Aneurysm Repair Products 75
8 Pipeline Assessment 86
8.1 Overview 86
8.2 Product Profiles 86
8.2.1 Altura Medical Endograft 86
8.2.2 Cordis INCRAFT 87
8.2.3 EndoSpan Horizon 88
8.2.4 EndoSpan Nexus 89
8.2.5 MicroPort Scientific Castor Branched Stent Graft System 90
8.2.6 BiFlow Medical Novel Side-Branch Stent 91
8.2.7 Endoluminal Sciences Endograft Mechanism 92
8.2.8 Medtronic Valiant Mona LSA Stent Graft System 93
8.2.9 Endologix Ventana Fenestrated Stent Graft 93
9 Clinical Trials to Watch 95
9.1 Overview 95
9.2 Altura Medical 95
9.3 Cook Medical 96
9.4 Gore Medical 98
9.5 Terumo Corporation 99
9.6 Endologix 99
9.7 TriVascular 101
9.8 Bolton Medical 102
9.9 Medtronic 103
9.10 Cordis Corporation 105
10 Current and Future Players 106
10.1 Overview 106
10.2 Trends in Corporate Strategy 106
10.3 Company Profiles 107
10.3.1 Cook Medical 107
10.3.2 Endologix 110
10.3.3 Gore Medical 113
10.3.4 Medtronic 115
10.3.5 Terumo Corporation 118
10.3.6 Altura Medical 120
10.3.7 Aptus Endosystems 121
10.3.8 Bolton Medical 123
10.3.9 Braile Biomedica 126
10.3.10 B. Braun 128
10.3.11 Cardiatis 129
10.3.12 LeMaitre Vascular 131
10.3.13 Lifetech Scientific 133
10.3.14 Getinge Group 135
10.3.15 Grikin Advanced Materials 138
10.3.16 Johnson and Johnson's Cordis Corporation 139
10.3.17 Jotec 141
10.3.18 Lombard Medical 143
10.3.19 MicroPort Scientific Corporation 144
10.3.20 Nano Endoluminal 147
10.3.21 TriVascular 149
10.3.22 Weike Medical Apparatus and Instrument 152
10.3.23 YTH Biological Material Scitech 152
11 Market Outlook 153
11.1 By Market Segment 153
11.1.1 Endovascular Aneurysm Repair 153
11.1.2 Thoracic Endovascular Aneurysm Repair 154
11.2 By Geography 155
11.2.1 South America 155
12 Appendix 158
12.1 Bibliography 158
12.2 Abbreviations 172
12.3 Research Methodology 175
12.3.1 Overview 175
12.3.2 Coverage 175
12.3.3 Secondary Research 175
12.4 Physicians and Specialists Included in this Study 177
12.4.1 Christopher Abularrage, MD, FACS 177
12.4.2 Gaspar Mestres Alomar, MD 177
12.4.3 Enio Buffolo, MD, PhD 177
12.4.4 Ludovic Canaud, MD, PhD 177
12.4.5 Holger Eggebrecht, MD 177
12.4.6 Daisuke Fukui, MD, PhD 177
12.4.7 Germano Melissano, MD 177
12.4.8 Dr. Raghuram Sekhar MS, FRCS (Edinburgh), FRCS (Glasgow) 177
12.4.9 Ferdinand Serracino-Inglott, MD, MSc, FRCSI, FRCS (Gen Surg), DIC 178
12.4.10 Jiang Xiong, MD, PhD 178
12.5 Primary Research 179
12.5.1 Primary Research - Key Opinion Leader Interviews 179
12.5.2 Primary Research - Physician and Industry Interviews 179
12.5.3 Expert Panel Validation 180
12.6 Forecasting Methodology 181
12.7 About the Authors 182
12.7.1 Analysts 182
12.7.2 Global Head of Healthcare 183
12.8 About MediPoint 184
12.9 About GlobalData 184
12.10 Disclaimer 184

1.1 List of Tables

Table 1: Summary of Indications, Symptoms, and Treatments 23
Table 2: Thoracic Aortic Aneurysm Types 25
Table 3: Medications for Reducing Risk of Aneurysm Growth and Rupture 28
Table 4: Advantages and Disadvantages of Open Repair versus Endovascular Repair 30
Table 5: Direct and Indirect Costs of Open Surgery and Endovascular Repair 44
Table 6: Comparison Costs and Other Variables for Treating AAA By Open Repair and Stent Grafts in 2012 ($US) 45
Table 7: Endoleak Types 46
Table 8: Zenith Family Marketed Products 77
Table 9: Zenith AAA SWOT 77
Table 10: Zenith TAA SWOT 78
Table 11: Endologix's Marketed Products 79
Table 12: AFX Endovascular SWOT 79
Table 13: IntuiTrak Powerlink System SWOT 79
Table 14: Gore Medical's Marketed Products 81
Table 15: Gore AAA Product SWOT 81
Table 16: Gore TAA Product SWOT 82
Table 17: Medtronic's Marketed Products 83
Table 18: Medtronic AAA Product SWOT 84
Table 19: Medtronic TAA Product SWOT 84
Table 20: Terumo Corporation Marketed Products 85
Table 21: Terumo Corporation AAA Product SWOT 85
Table 22: SWOT Analysis - Altura Medical Endograft 87
Table 23: SWOT Analysis - Cordis INCRAFT 88
Table 24: SWOT Analysis - EndoSpan Horizon 89
Table 25: SWOT Analysis - EndoSpan Nexus 90
Table 26: SWOT Analysis - MicroPort Scientific Castor Branched Stent Graft System 91
Table 27: SWOT Analysis - BiFlow Medical Novel Side-Branch Stent 92
Table 28: SWOT Analysis - Endoluminal Sciences Endograft Mechanism 92
Table 29: SWOT Analysis - Medtronic Valiant Mona LSA Stent Graft 93
Table 30: SWOT Analysis - Endologix Ventana Fenestrated Stent Graft 94
Table 31: Major Clinical Trials of Altura Medical's Aortic Stent Grafts 96
Table 32: Major Clinical Trials of Cook Medical's Aortic Stent Grafts 97
Table 33: Major Clinical Trials of Gore Medical's Aortic Stent Grafts 98
Table 34: Major Clinical Trials of Terumo's Aortic Stent Grafts 99
Table 35: Major Clinical Trials of Endologix's Aortic Stent Grafts 100
Table 36: Major Clinical Trials of TriVascular's Aortic Stent Grafts 101
Table 37: Major Clinical Trials of Bolton Medical's Aortic Stent Grafts 102
Table 38: Major Clinical Trials of Medtronic's Aortic Stent Grafts 103
Table 39: Major Clinical Trials of Cordis' Aortic Stent Grafts 105
Table 40: Company Profile - Cook Medical 108
Table 41: Cook Medical Marketed Products 109
Table 42: SWOT Analysis - Cook Medical 110
Table 43: Company Profile - Endologix Inc. 111
Table 44: Endologix Marketed Products 112
Table 45: Endologix Pipeline Products 112
Table 46: SWOT Analysis - Endologix Inc. 112
Table 47: Company Profile - Gore Medical 113
Table 48: Gore Medical Marketed Products 114
Table 49: SWOT Analysis - Gore Medical 115
Table 50: Company Profile - Medtronic 116
Table 51: Medtronic Marketed Products 117
Table 52: SWOT Analysis - Medtronic 117
Table 53: Company Profile - Terumo Corporation 118
Table 54:Terumo Corporation Marketed Products 119
Table 55: SWOT Analysis - Terumo Corporation 120
Table 56: Company Profile - Altura Medical Inc. 120
Table 57: Altura Medical Inc. Marketed Products 121
Table 58: SWOT Analysis - Altura Medical Inc. 121
Table 59: Company Profile - Aptus Endosystems, Inc. 122
Table 60: Aptus Endosystems Inc. Marketed Products 123
Table 61: SWOT Analysis - Aptus Endosystems Inc. 123
Table 62: Company Profile - Bolton Medical 124
Table 63: Bolton Medical Marketed Products 125
Table 64: SWOT Analysis - Bolton Medical 125
Table 65: Company Profile - Braile Biomedica 126
Table 66: Braile Biomedica Marketed Products 127
Table 67: SWOT Analysis - Braile Biomedica 127
Table 68: Company Profile - B. Braun 128
Table 69: B. Braun Marketed Products 129
Table 70: SWOT Analysis - B. Braun 129
Table 71: Company Profile - Cardiatis 130
Table 72: Cardiatis Marketed Products 130
Table 73: SWOT Analysis - Cardiatis 131
Table 74: Company Profile - LeMaitre Vascular 132
Table 75: LeMaitre Vascular Medical Marketed Products 132
Table 76: SWOT Analysis - LeMaitre Vascular 133
Table 77: Company Profile - Lifetech Scientific 134
Table 78: Lifetech Scientific Marketed Products 134
Table 79: SWOT Analysis - Lifetech Scientific 135
Table 80: Company Profile - Getinge Group 136
Table 81: Getinge Group Marketed Products 137
Table 82: SWOT Analysis - Getinge Group 137
Table 83: Company Profile - Grikin Advanced Materials 138
Table 84: Grikin Advanced Materials Marketed Products 138
Table 85: SWOT Analysis - Grikin Advanced Materials 139
Table 86: Company Profile - Johnson and Johnson Cordis Corporation 139
Table 87: Cordis Corporation's Pipeline Product 140
Table 88: SWOT Analysis - Cordis Corporation 140
Table 89: Company Profile - Jotec 141
Table 90: Jotec's Marketed Products 142
Table 91: SWOT Analysis - Jotec 142
Table 92: Company Profile - Lombard Medical 143
Table 93: Lombard Medical Marketed Products 144
Table 94: SWOT Analysis - Lombard Medical 144
Table 95: Company Profile - Microport Scientific Corporation 145
Table 96: MicroPort Scientific Marketed Products 146
Table 97: SWOT Analysis - MicroPort Scientific 147
Table 98: Company Profile - Nano Endoluminal 148
Table 99: Nano Endoluminal Medical Marketed Products 148
Table 100: SWOT Analysis - Nano Endoluminal 149
Table 101: Company Profile - TriVascular 150
Table 102: TriVascular Marketed Products 151
Table 103: SWOT Analysis - TriVascular 151
Table 104:South America Aortic Stent Grafts Sales ($m) Forecast, EVAR, 2011-2020 153
Table 105: South America Aortic Stent Grafts Sales ($m) Forecast, TEVAR, 2011-2020 154
Table 106: Aortic Stent Grafts Sales ($m) Forecast for Brazil, 2011-2020 156

1.2 List of Figures

Figure 1: Treatment Methodology Markov Model 27
Figure 2: Aortic Stent Graft Product Image 30
Figure 3: South America Abdominal Aortic Stent Grafts Procedure Volume, 2011-2020 31
Figure 4: South America Thoracic Aortic Stent Grafts Procedure Volume, 2011-2020 32
Figure 5: South America Aortic Stent Grafts Sales ($m) Forecast, EVAR, 2011-2020 153
Figure 6: South America Aortic Stent Grafts Sales ($m) Forecast, TEVAR, 2011-2020 154
Figure 7: Brazil Sales ($m) Forecast for Aortic Stent Grafts, 2011-2020 157
Figure 8: Aortic Stent Graft Primary Research, Supply and Demand-Side Interviews 180

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Vascular Access Devices Market: Scope and Methodology Vascular access devices are medical devices used to obtain access to the bloodstream, and are hollow and flexible tubes made of latex, silicone, and ...

Czech Republic Interventional Cardiology Market Outlook to 2022

Czech Republic Interventional Cardiology Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Interventional Cardiology Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Interventional Cardiology Market Outlook to 2022, provides key market data on the Czech ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.